← Leaderboards
Anna Moszczynska
University Of Toledo Health Sci Campus
$3,475,705
Attributed
$3,475,705
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $342K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,475,705 · 4
By mechanism
R01$2,564,365 · 2
R00$732,060 · 1
K99$179,280 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neuroprotection”
- Sharon A Nachman · Johns Hopkins University$42,420,770
- Stuart A Lipton · Burnham Institute For Medical Research$33,291,537
- Jane S Paulsen · University Of Wisconsin-Madison$30,187,749
- Myron D Ginsberg · University Of Miami School Of Medicine$27,285,244
- Steven M Hersch · Emory University$27,111,545
- Karl D. Kieburtz · University Of Rochester$25,397,249
Research focus
NeuroprotectionNeuronsOverdoseUbiquitin-Protein LigasePharmaceutical PreparationsImpairmentToxic EffectProteinsUbiquitinMediatingMethamphetamineMolecularMulticatalytic Endopeptidase ComplexOxidative StressDoseNeurotoxicityOverexpressionParkin Gene/ProteinPharmacologic SubstanceCell DeathIn VivoLeadImpaired CognitionBase
Grant awards (13)
Investigating Parkin-mediated Neuronal Energy Maintenance in Methamphetamine Use Disorder$278,045
R01 · FY2025 · DA · contact PI
Investigating Parkin-mediated Neuronal Energy Maintenance in Methamphetamine Use Disorder$286,113
R01 · FY2024 · DA · contact PI
Investigating Parkin-mediated Neuronal Energy Maintenance in Methamphetamine Use Disorder$317,757
R01 · FY2023 · DA · contact PI
PROTEASOME AND PARKIN AS DRUG TARGETS AGAINST METHAMPHETAMINE TOXICITY$342,000
R01 · FY2017 · DA · contact PI
PROTEASOME AND PARKIN AS DRUG TARGETS AGAINST METHAMPHETAMINE TOXICITY$338,580
R01 · FY2016 · DA · contact PI
PROTEASOME AND PARKIN AS DRUG TARGETS AGAINST METHAMPHETAMINE TOXICITY$336,870
R01 · FY2015 · DA · contact PI
PROTEASOME AND PARKIN AS DRUG TARGETS AGAINST METHAMPHETAMINE TOXICITY$342,000
R01 · FY2014 · DA · contact PI
PROTEASOME AND PARKIN AS DRUG TARGETS AGAINST METHAMPHETAMINE TOXICITY$323,000
R01 · FY2013 · DA · contact PI
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)$241,530
R00 · FY2012 · DA · contact PI
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)$241,530
R00 · FY2011 · DA · contact PI
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)$249,000
R00 · FY2010 · DA · contact PI
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)$89,640
K99 · FY2009 · DA · contact PI
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)$89,640
K99 · FY2008 · DA · contact PI